Sentinel Oncology
Sentinel Oncology is focused on the development and commercialization of new therapeutics for oncology and diseases with a high unmet need. Founded in 2005 in Cambridge, UK, the company works to address the needs of patients with cancer.
- Oncology candidate drugs
- Targeted cancer therapies
- Drug discovery and development
Locations
Competitors
Exscientia is a technology-driven company focused on AI drug discovery, aiming to revolutionise the pharmaceutical industry through precision medicine.
Exvastat Ltd is a biotechnology company focused on developing innovative treatments for Acute Respiratory Distress Syndrome (ARDS).
AstraZeneca is a research-based bio-pharmaceutical company that focuses on the discovery, development, and commercialisation of innovative medicines.
Company Details
Sentinel Oncology is operated by Sentinel Oncology Limited and is a Active company incorporated on 19 January 2005 with the registered office located in Cambridge, Cambridgeshire. Sentinel Oncology Limited was registered 20 years ago.
Status
Active
Size
Micro
Directors
7
Age
20 years old
Employees
5
Turnover
Unreported
Total Assets
£5.81M
Cash in Bank
£5.56M
Total Liabilities
-£402.33K
Teams
4
2
1
1
Non Executive Director • Joined Mar 2011
Director Of Chemistry • Joined Sep 2018
Administrator
Employee
Non Executive Director • Joined Mar 2011
Director Of Chemistry • Joined Sep 2018
Administrator
Employee